---
schema_version: "secwatch.filing_event.v1"
accession: "0000926617-23-000016"
form_type: "8-K"
ticker: "AWHL"
cik: "0000926617"
company_name: "Aspira Women's Health Inc."
filed_at: "2023-03-03T23:59:59+00:00"
generated_at: "2026-06-18T13:59:19.725266+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Aspira Women's Health appoints Dr. Jordan as Chair; Palmieri resigns as Executive Chair and director

## Summary
- Dr. Veronica G.H. Jordan appointed Chair of the Board, effective March 1, 2023.
- Dr. Robert Auerbach stepped down as Lead Independent Director, effective March 1, 2023.
- Valerie Palmieri's term as Executive Chair concluded March 1, 2023; she resigned from the Board.
- Palmieri's departure follows the terms of her Amended and Restated Employment Agreement dated March 1, 2022.

## SEC filing metadata
- accession: 0000926617-23-000016
- form_type: 8-K
- ticker: AWHL
- cik: 0000926617
- company_name: Aspira Women's Health Inc.
- filed_at: 2023-03-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/0000926617-23-000016-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/awh-20230228x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000926617-23-000016
- JSON: https://secwatch.observer/filing/0000926617-23-000016.json
- Plain text: https://secwatch.observer/filing/0000926617-23-000016.txt

## Key facts
- Executive change
  Valerie Palmieri resigned as Executive Chair at Aspira Women's Health Inc..
  - Action: resigned
  - Role: Executive Chair
  source text: Ms. Palmieri’s term as Executive Chair of the Company concluded on March 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/0000926617-23-000016-index.htm
- Executive change
  Dr. Robert Auerbach changed role as Lead Independent Director at Aspira Women's Health Inc..
  - Action: stepped down
  - Role: Lead Independent Director
  source text: Dr. Robert Auerbach stepped down as the Company’s Lead Independent Director, effective as of March 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/0000926617-23-000016-index.htm
- Executive change
  Dr. Veronica G.H. Jordan was appointed as Chair of the Board at Aspira Women's Health Inc..
  - Action: appointed
  - Role: Chair of the Board
  source text: the board of directors (the “Board”) of Aspira Women’s Health Inc. (the “Company”) appointed Dr. Veronica G.H. Jordan as the Chair of the Board , effective as of March 1, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/926617/000092661723000016/0000926617-23-000016-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.